LLY
974.96
-1.19%↓
JNJ
222.47
-0.89%↓
ABBV
202.58
-1.21%↓
UNH
369.71
+0.7%↑
AZN
182.23
-1.36%↓
LLY
974.96
-1.19%↓
JNJ
222.47
-0.89%↓
ABBV
202.58
-1.21%↓
UNH
369.71
+0.7%↑
AZN
182.23
-1.36%↓
LLY
974.96
-1.19%↓
JNJ
222.47
-0.89%↓
ABBV
202.58
-1.21%↓
UNH
369.71
+0.7%↑
AZN
182.23
-1.36%↓
LLY
974.96
-1.19%↓
JNJ
222.47
-0.89%↓
ABBV
202.58
-1.21%↓
UNH
369.71
+0.7%↑
AZN
182.23
-1.36%↓
LLY
974.96
-1.19%↓
JNJ
222.47
-0.89%↓
ABBV
202.58
-1.21%↓
UNH
369.71
+0.7%↑
AZN
182.23
-1.36%↓
Преглед
Промяна на цената на акция
24 ч
Текуща
Минимум
26.06
Максимум
26.69
Препоръки | Купи |
|---|---|
12-месечна прогноза | +74.34% upside |
Следващи печалби | 4.08.2026 г. |
|---|
Rigel Pharmaceuticals Inc Графика
Миналото представяне не гарантира бъдещи резултати.
Свързани новини
7.05.2026 г., 22:57 ч. UTC
Australia's Macquarie Beats Consensus With 30% Fiscal Year Profit Jump
DJ
Прочетени
7.05.2026 г., 23:52 ч. UTC
CoreWeave Stock Dives on Weak Outlook -- Barrons.com
DJ
Прочетени
7.05.2026 г., 23:45 ч. UTC
Nikkei May Decline Amid Middle East Uncertainty -- Market Talk
DJ
Прочетени
7.05.2026 г., 23:43 ч. UTC
OCBC's First-Quarter Net Profit Rose on Record Noninterest Income
DJ
Прочетени
7.05.2026 г., 23:39 ч. UTC
Gold Rises on Signs of Ongoing U.S.-Iran Tensions -- Market Talk
DJ
Прочетени
7.05.2026 г., 23:28 ч. UTC
Australian Budget Set to Contain A$64B in Spending Cuts-- Market Talk
DJ
Прочетени
7.05.2026 г., 23:11 ч. UTC
OCBC Group CEO: Well-Positioned to Navigate Uncertainties, Deliver Sustainable Long-Term Value >O39.SG
DJ
Прочетени
7.05.2026 г., 23:06 ч. UTC
Oversea-Chinese Banking Corp. 1Q Net Interest Margin 1.76%, Down 28 Bps on Year >O39.SG
DJ
Прочетени
7.05.2026 г., 23:05 ч. UTC
Oversea-Chinese Banking Corp.: Solid 1Q Performance Underpinned by Record Non-Interest Income >O39.SG
DJ
Прочетени
7.05.2026 г., 23:04 ч. UTC
Oversea-Chinese Banking Corp. 1Q Non-Interest Income S$1.61B Vs. S$1.31B >O39.SG
DJ
Прочетени
7.05.2026 г., 23:03 ч. UTC
Oversea-Chinese Banking Corp. 1Q Net Interest Income S$2.22B Vs. S$2.35B >O39.SG
DJ
Прочетени
7.05.2026 г., 23:03 ч. UTC
Oversea-Chinese Banking Corp. 1Q Net S$1.97B Vs. Net S$1.88B >O39.SG
DJ
Прочетени
7.05.2026 г., 23:02 ч. UTC
Oversea-Chinese Banking Corp. 1Q Total Income S$3.83B Vs. S$3.66B >O39.SG
DJ
Прочетени
7.05.2026 г., 23:00 ч. UTC
Australia's Federal Budget Likely to Contain Significant Reforms -- Market Talk
DJ
Прочетени
7.05.2026 г., 22:45 ч. UTC
Global Forex and Fixed Income Roundup: Market Talk
DJ
Прочетени
7.05.2026 г., 22:45 ч. UTC
Lyft Says Efforts to Service Waymo's AVs Are Underway -- Market Talk
DJ
Прочетени
7.05.2026 г., 22:42 ч. UTC
Australia's Macquarie Beats Consensus With 30% FY Profit Jump
DJ
Прочетени
7.05.2026 г., 22:33 ч. UTC
Gilead Stock Falls. A Massive Acquisition Spree Is Coming at a Cost. -- Barrons.com
DJ
Прочетени
7.05.2026 г., 22:32 ч. UTC
Macquarie FY Total Customer Deposits A$221.5B Vs. A$177.7B>MQG.AU
DJ
Прочетени
7.05.2026 г., 22:31 ч. UTC
Macquarie FY Return on Equity 14.0% Vs. 11.2%>MQG.AU
DJ
Прочетени
7.05.2026 г., 22:31 ч. UTC
Macquarie: 68% of FY Income From International >MQG.AU
DJ
Прочетени
7.05.2026 г., 22:30 ч. UTC
Macquarie Bank Year-End CET1 Level 2 Ratio 12.8%>MQG.AU
DJ
Прочетени
7.05.2026 г., 22:30 ч. UTC
Macquarie Capital Surplus A$9.3B at March 31 Vs. A$9.5B a Year Earlier>MQG.AU
DJ
Прочетени
7.05.2026 г., 22:29 ч. UTC
Macquarie CEO: Well-Positioned for Superior Medium-Term Performance>MQG.AU
DJ
Прочетени
7.05.2026 г., 22:28 ч. UTC
Macquarie: Continues a Conservative Approach to Capital, Funding, Liquidity>MQG.AU
DJ
Прочетени
7.05.2026 г., 22:28 ч. UTC
Macquarie: Continues to Maintain a Cautious Stance>MQG.AU
DJ
Прочетени
7.05.2026 г., 22:27 ч. UTC
Macquarie: Decision Recognizes Prevailing Market Conditions>MQG.AU
DJ
Прочетени
7.05.2026 г., 22:27 ч. UTC
Macquarie Has Not Purchased Shares Since Extending the Buyback>MQG.AU
DJ
Прочетени
7.05.2026 г., 22:26 ч. UTC
Macquarie to End Share Buyback Extended in November>MQG.AU
DJ
Прочетени
7.05.2026 г., 22:25 ч. UTC
Macquarie Commodities and Global Markets FY Net Profit Contribution A$4.2B, Up 49% on Year>MQG.AU
DJ
Прочетени
Сравнение с други в отрасъла
Ценова промяна
Rigel Pharmaceuticals Inc Прогноза
Ценова цел
By TipRanks
12-месечна прогноза
Среден 51.5 USD 74.34%
Висок 71 USD
Нисък 38 USD
Според 4 анализатори от Wall Street, предложили 12-месечна ценова цел за Rigel Pharmaceuticals Inc през последните три месеца.
Консенсусна оценка
By TipRanks
Купи
4 ratings
2
Купи
2
Задържане
0
Продай
Според 4 анализатори, дали борсови рейтинги на Rigel Pharmaceuticals Inc през последните 3 месеца.
Финанси
$